By the end of this module
Recognise the broad clinical footprint of endometriosis, including extra-pelvic and GI-adjacent presentations.
Remember this
Classification systems describe disease; they do not reliably predict pain, fatigue, or quality-of-life impact.
InsideHer stance
Keep language clinically grounded, avoid minimising symptoms, and avoid overexplaining the condition through a single mechanism.
Clinical frame
Think in patterns: cycle-linked pain, bowel symptoms, fatigue, fertility concerns, and function loss often travel together.
Definition and distribution
Endometriosis is a common inflammatory gynaecological condition in which tissue similar to endometrium grows outside the uterus. It commonly affects the peritoneum, ovaries, and fallopian tubes, but it can also affect the bladder, bowel, lungs, and more distant sites. A practical takeaway for clinicians is that pelvic symptoms are common, but pelvic location alone should not narrow thinking too early when cyclical extra-pelvic symptoms are present.
Prevalence and burden
The attached course material notes that prevalence estimates vary internationally, while Australian estimates suggest endometriosis may affect around 1 in 7 females up to ages 44 to 49 when clinically suspected and surgically confirmed cases are combined. The burden extends well beyond pain. Work, study, social life, relationships, fertility, mental health, and finances are all commonly affected.
Clinical InsightSeverity score is not a pain score
The source material is explicit that commonly used classification systems correlate poorly with symptoms, quality of life, and outcomes. More disease on paper does not reliably mean more pain in the room.
Classification systems
Common systems include rASRM, Endofound, ENZIAN, and the Endometriosis Fertility Index.
Most used in Australia
The course source identifies rASRM as the most commonly used staging system in Australia.
Disease trajectory
Untreated disease is not inevitably progressive. Some cases progress, some remain stable, and some regress.
Central sensitisation
Pain can become amplified over time, which helps explain persistent symptoms despite treatment.
Risk markers worth noticing
First-degree relative with endometriosis. Heavy periods, early menarche, or short cycles. Fertility concerns or nulliparity in the wider clinical picture. Low BMI or a history suggesting gynaecological structural differences.
What this condition is not
Not just “bad period pain.” Not always confined to the pelvis. Not reliably captured by one scan, one test, or one symptom score. Not best managed by a single-discipline response when symptoms are complex.